Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TRY 27.14 million compared to TRY 124.91 million a year ago. Net income was TRY 11.92 million compared to TRY 163.41 million a year ago.
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
Equities
ANGEN
TREANGN00028
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.28 TRY | -1.12% | -5.41% | +6.67% |
1st Jan change | Capi. | |
---|---|---|
+6.67% | 90.18M | |
+0.17% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B | |
-18.08% | 9.94B |
- Stock Market
- Equities
- ANGEN Stock
- News Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret
- Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Reports Earnings Results for the First Quarter Ended March 31, 2023